On the recordMay 18, 2021
Emergent should not be in the business of developing vaccines, whether it is trying to work with Johnson & Johnson or AstraZeneca or anybody else, because they cannot be trusted.
Source
congress.govEmergent should not be in the business of developing vaccines, whether it is trying to work with Johnson & Johnson or AstraZeneca or anybody else, because they cannot be trusted.
Clyburn expresses distrust in Emergent's ability to safely develop vaccines.
Share
More from Jim Clyburn
13 is a pretty good number. A baker’s dozen would be a good number to have on the Court.
I never saw anything that allowed me to think that Joe Biden was not able to do the job. Just that simple.
Reductions to DOT’s workforce [could] halt any meaningful progress in transportation safety.